SCHEMBL1817201

SCHEMBL1817201

O=C(O)c1cccc(NC(=O)c2cccnc2F)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.55
NPC1 O15118 3/20 0.55
RAB9A P51151 3/20 0.55
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
ALDH1A1 P00352 1/20 0.54
NAPRT Q6XQN6 1/20 0.54
LCLAT1 Q6UWP7 1/20 0.53
HTT P42858 1/20 0.52
HPSE Q9Y251 1/20 0.51
KCNK3 O14649 1/20 0.50
KCNK9 Q9NPC2 1/20 0.50
CA12 O43570 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
CREBBP Q92793 1/20 0.49
PRKCI P41743 1/20 0.49
KDM4E B2RXH2 2/20 0.48
MAPT P10636 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2105320 0.99 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL2105318 0.88 LCLAT1 (0.52) SMN1; SMN2NPC1MEN1KMT2AALDH1A1
SCHEMBL1810078 0.86 RAB9A (0.59) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL4599740 0.84 PRKCI (0.67) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL1805499 0.84 MEN1 (0.67) SMN1; SMN2NPC1RAB9AMEN1KMT2A
Hydrochloric Acid SCHEMBL2106811 0.83 MEN1 (0.65) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL1810665 0.80 MEN1 (0.81) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL3606020 0.79 SMN1; SMN2 (0.65) SMN1; SMN2NPC1RAB9AMEN1KMT2A
Hydrochloric Acid SCHEMBL2103872 0.79 MEN1 (0.78) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL2058337 0.78 ALDH1A1 (0.71) SMN1; SMN2NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110201603-A1 Novel Acylaminobenzamide Derivatives BAYER CROPSCIENCE AG (DE) 2011-08-18 US disclosed
EP-2318358-A2 ACYLAMINOBENZAMIDE DERIVATIVES Bayer CropScience AG (DE) 2011-05-11 EP disclosed
WO-2010015355-A2 NOVEL ACYLAMINOBENZAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-02-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201603-A1 Novel Acylaminobenzamide Derivatives KCNB1, KCNA5, KCNA7 SMN1; SMN2 4532/4885NPC1 3104/4885RAB9A 742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.